NR4A1 and breast carcinoma: The postmenopausal women with hormone-sensitive early breast cancer (POETIC) study was a phase 3 trial in which postmenopausal hormone receptor-positive early breast cancer patients were randomly assigned to POAI (letrozole or anastrozole) for 14 days before and following surgery or no POAI (control) (38).